About the Journal
Journal of Cancer Biomoleculars and Therapeutics (JCBT) encompasses a broad range of research areas on clinical and experimental research of cancer. The scope includes, but not limited to:
- Molecular Oncology
Studies focusing on the molecular mechanisms that lead to cancer development and progression. This can include research on oncogenes, tumor suppressors, cancer genomics, and epigenetics.
- Cancer Therapeutics
Research on developing new treatments for cancer, including chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. This may also cover drug design, development, and delivery systems.
- Biomarkers in Cancer
Identification and validation of biomarkers for cancer diagnosis, prognosis, and treatment response.
- Cancer Cell Biology
Investigations into cancer cell behavior, signaling pathways, cell cycle regulation, apoptosis, and tumor microenvironment.
- Translational Research
Bridging basic science findings to clinical applications, such as the development of new diagnostic tools or therapeutic strategies based on molecular findings.
- Personalized Medicine in Oncology
Research into individualized treatment approaches based on genetic, biomolecular, and phenotypic characteristics of both the tumor and the patient.
- Pharmacology and Toxicology
Studies on the pharmacodynamics and pharmacokinetics of cancer drugs, including their toxicological impacts.
- Cancer Prevention and Epidemiology
Research on cancer risk factors, preventive strategies, and the epidemiology of different types of cancer.
- Clinical Trials
Reports on the outcomes of clinical trials for new cancer treatments, including phase I, II, III, and IV trials.
- Innovative Therapeutic Approaches
Exploration of novel strategies in cancer treatment, such as gene therapy, nanotechnology in drug delivery, and new radiation therapy techniques.
